Sharing innovation to inspire action

A vaccine to control the mosquito population and prevent infection

post-image
The vaccine could work by creating an anti-saliva immune response in humans that prevents infection. In addition, after the mosquito bites a vaccinated human host, antibodies from the human attack the gut and salivary glands of the mosquito which reduces the survival of the mosquito. If successful in its imminent Zika clinical study, Imutex will further develop the technology in other mosquito-borne illnesses, including malaria, dengue and West Nile. http://imutex.com/index.php/zika-vaccine-programme/
What do you think?

You must be logged in to post a comment.
Comments
Generic placeholder image

By Lynn Wood

2 February 2019

 
0 Like


Related Posts

Healthcare

post-image

Artificial heart to be sold in Europe
21 January 2021 by Jenny Morawsk... 0 Comments
 
3 Like

Healthcare

post-image

Aussie biotech addressing sepsis with new diagnostic
14 January 2021 by Mel Raassina 0 Comments
 
5 Like

Healthcare

post-image

Data transfer from Computers to Living Cells
12 January 2021 by Jenny Morawsk... 0 Comments
 
6 Like